Emerson S G, Sieff C A, Gross R G, Rozans M K, Miller R A, Rappeport J M, Nathan D G
Division of Pediatric Hematology/Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Exp Hematol. 1987 Nov;15(10):1013-21.
Hematologic engraftment following bone marrow transplantation requires not only pluripotent stem cells but also functioning accessory cells whose trophic factors support the proliferation and differentiation of stem cells and progenitors to mature blood cells. To better understand the regulation of hematopoiesis following transplantation, we studied hemopoietic accessory cell function in bone marrow transplant recipients 3 weeks to 10 months following transplantation. In general, hematopoietic accessory cell function was decreased following bone marrow transplantation. Sequential fractionation of accessory cells demonstrated that adherent cells often produced near-normal functional burst-promoting activity (BPA) and granulocyte-macrophage colony-stimulating activity (GM-CSA), but Fc receptor-positive (Fc+) cells and T cells uniformly produced greatly reduced BPA and GM-CSA, as compared to transplant donor cells. This cellular deficiency was corrected by soluble burst-promoting activity and granulocyte-macrophage colony-stimulating activity and so appeared to be due to the failure of accessory cells to produce trophic hormones. Limiting-dilution analysis (LDA) for proliferating T-cell precursors demonstrated a greatly reduced frequency in phytohemagglutinin-responsive cells, supporting the role of deficient hematopoietic growth factor production by activated T cells in transplant recipients. This hemopoietic accessory cell defect may thus reflect more generalized lymphocyte dysfunction in these patients. Hematopoiesis following bone marrow transplantation appears to rely upon growth factors released by accessory cells in the adherent layer.
骨髓移植后的血液学植入不仅需要多能干细胞,还需要有功能的辅助细胞,其营养因子支持干细胞和祖细胞增殖并分化为成熟血细胞。为了更好地理解移植后造血的调控机制,我们研究了骨髓移植受者在移植后3周 至10个月的造血辅助细胞功能。一般来说,骨髓移植后造血辅助细胞功能会降低。辅助细胞的连续分级分离表明,贴壁细胞通常产生接近正常功能的爆式促进活性(BPA)和粒细胞-巨噬细胞集落刺激活性(GM-CSA),但与移植供体细胞相比,Fc受体阳性(Fc+)细胞和T细胞产生的BPA和GM-CSA均大幅降低。这种细胞缺陷可通过可溶性爆式促进活性和粒细胞-巨噬细胞集落刺激活性得到纠正,因此似乎是由于辅助细胞未能产生营养激素所致。对增殖性T细胞前体的极限稀释分析(LDA)表明,植物血凝素反应性细胞的频率大幅降低,这支持了移植受者中活化T细胞产生造血生长因子不足的作用。因此,这种造血辅助细胞缺陷可能反映了这些患者中更普遍的淋巴细胞功能障碍。骨髓移植后的造血似乎依赖于贴壁层辅助细胞释放的生长因子。